Results
1 -
2 of
2
(Click
here to explore results)
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 3 Natural Compounds and Synthetic Drugs to Target Type-1 Cannabinoid (CB1) Receptor. Christos Iliopoulos-Tsoutsouvas, Markos-Orestis Georgiadis, Lipin Ji, Spyros P. Nikas, Alexandros Makriyannis
, 2021
, Pages 48-88
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 5 Natural and Synthetic Cannabinoids Targeting Non-CB1, Non-CB2 G Protein-coupled Receptors. Paula Morales, Israa H. Isawi, Patricia H. Reggio
, 2021
, Pages 168-200